Skip to main content

Table 4 Multivariable Cox Proportional Hazards for transplant patient survival

From: Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study

 

HR (95% CI)

P

MPGN

0.61 (0.29–1.26)

0.18

Age

1.08 (1.04–1.12)

< 0.01

Male

0.80 (0.38–1.70)

0.57

Ethnicity

 Caucasian

Ref

0.11

 ATSI

18.36 (3.22–104.72)

 

 MPI

2.54 (0.70–9.16)

 

 sian

0.88 (0.11–6.82)

 

 Other

1.09 (0.01–10.3)

 

Hepatitis C Antibody Positive

5.97 (1.47–24.24)

0.01

Current Smoker

0.96 (0.34–2.76)

0.94

Diabetes Mellitus

0.47 (0.11–2.05)

0.31

Coronary Artery Disease

2.48 (0.89–6.90)

0.08

Peripheral Vascular Disease

0.83 (0.10–7.11)

0.87

Cerebrovascular Disease

2.00 (0.26–15.13)

0.50

Previous Diagnosis of Cancer

3.46 (1.06–11.25)

0.04

Chronic Lung Disease

3.79 (1.17–12.27)

0.03

First KRT modality

 HD

Ref

0.09

 PD

0.78 (0.31–1.98)

 

 Pre-emptive transplant

0.13 (0.02–1.07)

 

Late referral to dialysis

0.21 (0.05–0.97)

0.05

Transplant era 2007–16

1.97 (0.83–4.66)

0.12

  1. ATSI Aboriginal and Torres Strait Islander, MPI Maori and Pacific Islander, KRT Kidney replacement therapy, HD Hemodialysis, PD Peritoneal dialysis